ritholtzadmin

A Tale of Two Cities: Gold vs Biotechs

The below guest post comes to us from AllAboutTrends.com David reached out to me with his take on how low the price of gold could actually sink to. He sees it as the mirror image of the biotech sector right now, an area I am invested in that could be making a climax top. I…

361 Capital Weekly Research Briefing

361 Capital portfolio manager, Blaine Rollins, CFA, previously manager of the Janus Fund, writes a weekly update looking back on major moves, macro-trends and economic data points. The 361 Capital Weekly Research Briefing summarizes the latest market news along with some interesting facts and a touch of humor. 361 Capital is a provider of alternative…